SGRY Stock Summary and Trading Ideas (Surgery Partners | NASDAQ:SGRY)

Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.

Surgery Partners trades on the NASDAQ stock market under the symbol SGRY.

As of November 12, 2026, SGRY stock price declined to $26.58 with 3,398,854 million shares trading.

SGRY has a beta of 0.85, meaning it tends to be less sensitive to market movements. SGRY has a correlation of 0.02 to the broad based SPY ETF.

SGRY has a market cap of $3.48 billion. This is considered a Mid Cap stock.

Last quarter Surgery Partners reported $815 million in Revenue and $.16 earnings per share. This fell short of revenue expectation by $-46,976 and exceeded earnings estimates by $.09.

In the last 3 years, SGRY traded as high as $36.92 and as low as $11.41.

The top ETF exchange traded funds that SGRY belongs to (by Net Assets): DFSV, IWM, VTI, DFAT, VB.

SGRY has outperformed the market in the last year with a price return of +68.8% while the SPY ETF gained +12.0%. SGRY has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +77.2% and +14.4%, respectively, while the SPY returned -1.5% and -2.0%, respectively.

SGRY support price is $26.00 and resistance is $27.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SGRY shares will trade within this expected range on the day.